LOSS PER SHARE

9 Months Ended

Mar. 31, 2024

The following table sets forth the computation of basic and diluted net loss per share on the Consolidated Statements of Operations:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2024		2023		2024		2023
Numerator:


Net loss	$	(48,194)	$	(115,727)	$	(72,105)	$	(97,838)

Denominator:
Basic and diluted weighted average shares outstanding	89,832		89,421		89,718		89,369






Basic and diluted net loss per common share	$	(0.54)	$	(1.29)	$	(0.80)	$	(1.09)

Due to the incurred net loss in the three and nine months ended March 31, 2024, all common stock equivalents such as stock options and unvested restricted stock awards have been excluded from the computation of diluted net loss per share because the effect would have been anti-dilutive.

There were 329 restricted stock awards excluded from the calculation of diluted net loss per share for the three months ended March 31, 2023, as such awards were anti-dilutive. There were 524 stock-based awards comprised of restricted stock awards and stock options excluded from the calculation of diluted net loss per share for the nine months ended March 31, 2023, as such awards were anti-dilutive. Additionally, 885 and 399 stock-based awards outstanding at March 31, 2024 and 2023, respectively, were excluded from the calculation of diluted net loss per share for the three months ended March 31, 2024 and 2023, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Furthermore, 639 and 366 stock-based awards outstanding at March 31, 2024 and 2023, respectively, were excluded from the calculation of diluted net loss per share for the nine months ended March 31, 2024 and 2023, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.